| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
0.017 |
0.9 |
| mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
XMD11-85h |
GDSC1000 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |